Thrombotic complications in patients with newly diagnosed multiple myeloma treated with lenalidomide and dexamethasone: benefit of aspirin prophylaxis

被引：107
|
作者：
Zonder, JA [1 ]
Barlogie, B [1 ]
Durie, BGM [1 ]
McCoy, J [1 ]
Crowley, J [1 ]
Hussein, MA [1 ]
机构：
[1] Hudson Webber Canc Res Ctr, Karmanos Canc Inst, Detroit, MI 48201 USA
来源：
BLOOD | 2006年 / 108卷 / 01期
关键词：
D O I：
10.1182/blood-2006-01-0154
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：403 / 403
页数：1
相关论文
共 50 条
  • [21] Effective prophylaxis of thromboembolic complications with low molecular weight heparin in relapsed multiple myeloma patients treated with lenalidomide and dexamethasone
    Ulrike Klein
    Florentina Kosely
    Jens Hillengaß
    Michael Hundemer
    Stefan Schmitt
    Kai Neben
    Thomas Moehler
    Ute Hegenbart
    Anthony D. Ho
    Hartmut Goldschmidt
    [J]. Annals of Hematology, 2009, 88
  • [22] Oral ixazomib, lenalidomide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma
    Facon, Thierry
    Venner, Christopher P.
    Bahlis, Nizar J.
    Offner, Fritz
    White, Darrell J.
    Karlin, Lionel
    Benboubker, Lotfi
    Rigaudeau, Sophie
    Rodon, Philippe
    Voog, Eric
    Yoon, Sung-Soo
    Suzuki, Kenshi
    Shibayama, Hirohiko
    Zhang, Xiaoquan
    Twumasi-Ankrah, Philip
    Yung, Godwin
    Rifkin, Robert M.
    Moreau, Philippe
    Lonial, Sagar
    Kumar, Shaji K.
    Richardson, Paul G.
    Rajkumar, S. Vincent
    [J]. BLOOD, 2021, 137 (26) : 3616 - 3628
  • [23] STEM CELL MOBILIZATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA FOLLOWING THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE
    Kumar, S.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Dingli, D.
    Miceli, T.
    Litzow, M. R.
    Rajkumar, S. V.
    Gertz, M. A.
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 66 - 66
  • [24] Phase 2 Trial of Ixazomib, Lenalidomide, Dexamethasone and Daratumumab in Patients with Newly Diagnosed Multiple Myeloma
    Kumar, Shaji K.
    Kapoor, Prashant
    Laplant, Betsy
    Muchtar, Eli
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Dingli, David
    Go, Ronald S.
    Warsame, Rahma
    Kourelis, Taxiarchis
    Lust, John A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Hwa, Yi
    Fonder, Amie
    Hobbs, Miriam
    Leung, Nelson
    Rajkumar, S. Vincent
    Gertz, Morie A.
    Wolfe, Eric
    [J]. BLOOD, 2018, 132
  • [25] Carfilzomib, lenalidomide, and low-dose dexamethasone in elderly patients with newly diagnosed multiple myeloma
    Dytfeld, Dominik
    Jasielec, Jagoda
    Griffith, Kent A.
    Lebovic, Daniel
    Vesole, David H.
    Jagannath, Sundar
    Al-Zoubi, Ammar
    Anderson, Tara
    Detweiler-Short, Kristen
    Stockerl-Goldstein, Keith
    Ahmed, Asra
    Jobkar, Terri
    Durecki, Diane E.
    McDonnell, Kathryn
    Mietzel, Melissa
    Couriel, Daniel
    Kaminski, Mark
    Vij, Ravi
    Jakubowiak, Andrzej J.
    [J]. HAEMATOLOGICA, 2014, 99 (09) : E162 - E164
  • [26] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Newly Diagnosed Multiple Myeloma
    White, Darrell J.
    Lentzsch, Suzanne
    Gasparetto, Cristina
    Bahlis, Nizar
    Chen, Christine I.
    Lipe, Brea C.
    Schiller, Gary J.
    Tuchman, Sascha A.
    Sutherland, Heather J.
    Kotb, Rami
    Leblanc, Richard
    Sebag, Michael
    Venner, Christopher P.
    Callander, Natalie Scott
    Bensinger, William I.
    Sheehan, Heidi
    Chai, Yi
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Baljevic, Muhamed
    [J]. BLOOD, 2019, 134
  • [27] Lenalidomide plus dexamethasone effective in newly diagnosed myeloma
    Kate Matthews
    [J]. Nature Clinical Practice Oncology, 2006, 3 (3): : 116 - 117
  • [28] A 28 Day Schedule for Lenalidomide Bortezomib and Dexamethasone in Newly Diagnosed Multiple Myeloma
    Chari, Ajai
    Roper, Nitin
    Jagannath, Sundar
    [J]. BLOOD, 2011, 118 (21) : 1272 - 1273
  • [29] Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma
    Mark, Tomer M.
    Bowman, Isaac A.
    Rossi, Adriana C.
    Shah, Manan
    Rodriguez, Melissa
    Quinn, Ryann
    Pearse, Roger N.
    Zafar, Faiza
    Pekle, Karen
    Jayabalan, David
    Ely, Scott
    Coleman, Morton
    Chen-Kiang, Selina
    Niesvizky, Ruben
    [J]. LEUKEMIA & LYMPHOMA, 2014, 55 (12) : 2842 - 2849
  • [30] Daratumumab plus lenalidomide, bortezomib and dexamethasone in newly diagnosed multiple myeloma: Analysis of vascular thrombotic events in the GRIFFIN study
    Sborov, Douglas W.
    Baljevic, Muhamed
    Reeves, Brandi
    Laubach, Jacob
    Efebera, Yvonne A.
    Rodriguez, Cesar
    Costa, Luciano J.
    Chari, Ajai
    Silbermann, Rebecca
    Holstein, Sarah A.
    Anderson, Larry D., Jr.
    Kaufman, Jonathan L.
    Shah, Nina
    Pei, Huiling
    Patel, Sharmila
    Cortoos, Annelore
    Bartlett, J. Blake
    Vermeulen, Jessica
    Lin, Thomas S.
    Voorhees, Peter M.
    Richardson, Paul G.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (03) : 355 - 365
12345